Mirum Pharmaceuticals <MIRM.O>: Morgan Stanley cuts target price to $137.00 from $150.00
MIRM•Related News
Ascendis Pharma posts slide presentation on achondroplasia program updates
ASND•
Madrigal Pharmaceuticals to present at Canaccord Genuity Annual Growth Conference
MDGL•
BlackRock TCP Capital Q2 FY26 net investment income falls to $18.14 million; revenue drops to $40 million
TCPC•
Gilat demonstrates AI-based satellite interference detection, cancellation with up to 10x performance gain
GILT•
CRA International Q2 Adjusted EPS USD 2.16
CRAI•